Atlas Trials

A Trial of the Fatty Acid Amide Hydrolase Inhibitor Palmitoylethanolamide in Bipolar Depression

Clinical trial NCT06229977 · COMPLETED

Trial details

NCT number
NCT06229977
Sponsor
Rodrigo Machado-Vieira, MD, PhD, MSc
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Bipolar Depression
Start date
2023-05-17
Primary completion
2025-07-17
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.